SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-09-180485
Filing Date
2009-08-24
Accepted
2009-08-24 17:27:00
Documents
9
Period of Report
2009-08-23
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d8k.htm 8-K 32083
2 AGREEMENT AND PLAN OF MERGER dex101.htm EX-10.1 399147
3 FORM OF APLINDORE CONTINGENT VALUE RIGHTS AGREEMENT dex102.htm EX-10.2 68763
4 FORM OF H3 CONTINGENT VALUE RIGHTS AGREEMENT dex103.htm EX-10.3 70254
5 FORM OF MERCK CONTINGENT VALUE RIGHTS AGREEMENT dex104.htm EX-10.4 68954
6 FORM OF REAL ESTATE CONTINGENT VALUE RIGHTS AGREEMENT dex105.htm EX-10.5 68916
7 FORM OF VOTING AGREEMENT dex106.htm EX-10.6 43468
8 PRESS RELEASE dex991.htm EX-99.1 27792
9 GRAPHIC g58244g74e67.jpg GRAPHIC 10680
  Complete submission text file 0001193125-09-180485.txt   795809
Mailing Address 10275 SCIENCE CENTER DRIVE SAN DIEGO CA 92121-1117
Business Address 10275 SCIENCE CENTER DRIVE SAN DIEGO CA 92121-1117 858-550-7500
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

IRS No.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33093 | Film No.: 091032241
SIC: 2834 Pharmaceutical Preparations